KEVIN C TANG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN C TANG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN C TANG. KEVIN C TANG is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in NEOSE TECHNOLOGIES INC ($NTEC) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in PENWEST PHARMACEUTICALS CO ($PPCO) and Director in ACLARA BIOSCIENCES INC ($ACLA) and Director in Ardea Biosciences, Inc./DE ($IBPI) and 10% Owner in THRESHOLD PHARMACEUTICALS INC ($THLD) and 10% Owner in Northstar Neuroscience, Inc. ($NSTR) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA).
Latest Insider Trading Transactions of KEVIN C TANG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACLA, ARDM, IBPI, HRTX, MTEM, NTEC, NSTR, PPCO, GEVA, NPRO, VNDA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12 2011 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 0.26 | 400,000 | 104,000 | 400,000 | |
| Jul 01 2011 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 0.18 | 25,000,000 | 4,500,000 | 25,000,000 | |
| Jul 01 2011 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Grant | A | 0.15 | 50,000,000 | 7,500,000 | 60,436,506 | 10.4 M to 60.4 M (+479.09 %) |
| Jan 24 2011 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 26.00 | 212,000 | 5,512,000 | 3,307,112 | 3.1 M to 3.3 M (+6.85 %) |
| Jan 05 2011 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 25.97 | 12,500 | 324,625 | 12,500 | |
| Sep 22 2010 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Sell | U | 5.00 | 225,000 | 1,125,000 | 0 | 225 K to 0 (-100.00 %) |
| Sep 22 2010 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Sell | U | 5.00 | 6,396,598 | 31,982,990 | 0 | 6.4 M to 0 (-100.00 %) |
| May 26 2010 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Grant | A | 0.00 | 95,891 | 0 | 138,841 | 43 K to 138.8 K (+223.26 %) |
| Jan 19 2010 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Sell | S | 10.73 | 54,900 | 589,181 | 2,715,852 | 2.8 M to 2.7 M (-1.98 %) |
| Jan 13 2010 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Sell | S | 10.54 | 86,500 | 912,065 | 2,770,752 | 2.9 M to 2.8 M (-3.03 %) |
| Jan 13 2010 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Sell | S | 10.88 | 27,419 | 298,310 | 2,857,252 | 2.9 M to 2.9 M (-0.95 %) |
| Jan 13 2010 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Sell | S | 11.00 | 35,681 | 392,641 | 2,884,671 | 2.9 M to 2.9 M (-1.22 %) |
| Jan 06 2010 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Sell | S | 11.48 | 45,500 | 522,263 | 2,920,352 | 3 M to 2.9 M (-1.53 %) |
| Jan 06 2010 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Sell | S | 11.65 | 100,000 | 1,165,320 | 2,965,852 | 3.1 M to 3 M (-3.26 %) |
| Jan 06 2010 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 14.29 | 12,500 | 178,625 | 12,500 | |
| Oct 15 2009 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Option Exercise | S | 12.50 | 3,000 | 37,500 | 3,000 | |
| Oct 15 2009 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Option Exercise | S | 15.00 | 3,000 | 45,000 | 26,789 | |
| Oct 15 2009 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Sell | S | 11.80 | 57,928 | 683,782 | 3,065,852 | 3.1 M to 3.1 M (-1.85 %) |
| Oct 15 2009 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Sell | S | 12.76 | 542,072 | 6,918,844 | 3,123,780 | 3.7 M to 3.1 M (-14.79 %) |
| Oct 21 2009 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | P | 0.88 | 1,221,590 | 1,074,999 | 1,221,590 | |
| Oct 21 2009 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | P | 0.97 | 1,586,481 | 1,535,714 | 1,586,481 | |
| Oct 21 2009 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 0.88 | 2,443,181 | 2,149,999 | 10,436,506 | 8 M to 10.4 M (+30.57 %) |
| Jul 21 2009 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Option Exercise | S | 15.00 | 3,789 | 56,835 | 23,789 | |
| Jun 02 2009 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Option Exercise | S | 15.00 | 5,000 | 75,000 | 20,000 | |
| May 28 2009 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Option Exercise | S | 15.00 | 5,000 | 75,000 | 15,000 | |
| May 28 2009 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Option Exercise | S | 15.00 | 10,000 | 150,000 | 10,000 | |
| Mar 13 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.30 | 4,100 | 5,330 | 6,396,598 | 6.4 M to 6.4 M (+0.06 %) |
| Mar 13 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.36 | 21,000 | 28,560 | 6,392,498 | 6.4 M to 6.4 M (+0.33 %) |
| Mar 10 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.43 | 35,000 | 50,050 | 6,371,498 | 6.3 M to 6.4 M (+0.55 %) |
| Mar 10 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.39 | 296,362 | 411,884 | 6,336,498 | 6 M to 6.3 M (+4.91 %) |
| Mar 10 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.39 | 207,800 | 288,904 | 6,040,136 | 5.8 M to 6 M (+3.56 %) |
| Mar 10 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.46 | 101,500 | 148,403 | 5,832,336 | 5.7 M to 5.8 M (+1.77 %) |
| Mar 09 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.49 | 85,000 | 126,761 | 5,730,836 | 5.6 M to 5.7 M (+1.51 %) |
| Feb 27 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.50 | 69,200 | 103,572 | 5,645,836 | 5.6 M to 5.6 M (+1.24 %) |
| Feb 26 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.51 | 1,300 | 1,967 | 5,576,636 | 5.6 M to 5.6 M (+0.02 %) |
| Feb 25 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.42 | 24,140 | 34,238 | 5,575,336 | 5.6 M to 5.6 M (+0.43 %) |
| Feb 23 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.47 | 45,000 | 66,258 | 5,551,196 | 5.5 M to 5.6 M (+0.82 %) |
| Feb 19 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.65 | 665,000 | 1,096,652 | 5,506,196 | 4.8 M to 5.5 M (+13.74 %) |
| Jan 12 2009 | PPCO | PENWEST PHARMACEUT ... | TANG KEVIN C | 10% Owner | Buy | P | 1.99 | 1,015,000 | 2,023,403 | 4,841,196 | 3.8 M to 4.8 M (+26.53 %) |
| Jan 06 2009 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 12.16 | 2,500 | 30,400 | 20,000 | |
| Jan 06 2009 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 12.16 | 5,000 | 60,800 | 17,500 | |
| Jan 06 2009 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 12.16 | 12,500 | 152,000 | 12,500 | |
| Jan 05 2009 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.42 | 175,000 | 72,625 | 7,993,325 | 7.8 M to 8 M (+2.24 %) |
| Dec 02 2008 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Buy | P | 0.73 | 145,000 | 105,531 | 3,665,852 | 3.5 M to 3.7 M (+4.12 %) |
| Nov 12 2008 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Buy | P | 0.83 | 560,000 | 464,296 | 3,520,852 | 3 M to 3.5 M (+18.91 %) |
| Nov 12 2008 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Sell | J | 0.00 | 2,658,206 | 0 | 1,100,000 | 3.8 M to 1.1 M (-70.73 %) |
| Dec 17 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Sell | S | 2.54 | 41,800 | 105,967 | 4,100 | 45.9 K to 4.1 K (-91.07 %) |
| Dec 17 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Sell | S | 2.54 | 12,468 | 31,608 | 318,432 | 330.9 K to 318.4 K (-3.77 %) |
| Nov 20 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.19 | 275,000 | 326,838 | 3,463,926 | 3.2 M to 3.5 M (+8.62 %) |
| Nov 20 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 410,000 | 410,000 | 3,188,926 | 2.8 M to 3.2 M (+14.75 %) |
| Nov 17 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.25 | 400,000 | 499,920 | 2,778,926 | 2.4 M to 2.8 M (+16.81 %) |
| Nov 12 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Sell | J | 0.00 | 4,757,038 | 0 | 0 | 4.8 M to 0 (-100.00 %) |
| Oct 02 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.32 | 5,664 | 1,813 | 10,412,306 | 10.4 M to 10.4 M (+0.05 %) |
| Nov 12 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Sell | J | 0.00 | 7,472,414 | 0 | 0 | 7.5 M to 0 (-100.00 %) |
| Oct 01 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.33 | 2,800 | 924 | 10,406,642 | 10.4 M to 10.4 M (+0.03 %) |
| Dec 19 2008 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | P | 11.14 | 39,163 | 436,276 | 39,163 | |
| Dec 19 2008 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 11.14 | 156,652 | 1,745,103 | 3,320,112 | 3.2 M to 3.3 M (+4.95 %) |
| Nov 12 2008 | ARDM | ARADIGM CORP | TANG KEVIN C | 10% Owner | Sell | J | 0.00 | 5,310,000 | 0 | 0 | 5.3 M to 0 (-100.00 %) |
| Oct 23 2008 | ARDM | ARADIGM CORP | TANG KEVIN C | 10% Owner | Buy | P | 0.24 | 10,000 | 2,400 | 5,407,000 | 5.4 M to 5.4 M (+0.19 %) |
| Oct 22 2008 | ARDM | ARADIGM CORP | TANG KEVIN C | 10% Owner | Buy | P | 0.24 | 17,000 | 4,080 | 5,397,000 | 5.4 M to 5.4 M (+0.32 %) |
| Oct 15 2008 | ARDM | ARADIGM CORP | TANG KEVIN C | 10% Owner | Buy | P | 0.24 | 25,000 | 6,000 | 5,380,000 | 5.4 M to 5.4 M (+0.47 %) |
| Oct 14 2008 | ARDM | ARADIGM CORP | TANG KEVIN C | 10% Owner | Buy | P | 0.24 | 45,000 | 10,602 | 5,355,000 | 5.3 M to 5.4 M (+0.85 %) |
| Dec 22 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.48 | 415,300 | 200,673 | 7,818,325 | 7.4 M to 7.8 M (+5.61 %) |
| Nov 17 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.48 | 775,032 | 372,015 | 7,403,025 | 6.6 M to 7.4 M (+11.69 %) |
| Nov 17 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.50 | 66,000 | 32,710 | 6,627,993 | 6.6 M to 6.6 M (+1.01 %) |
| Oct 14 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.74 | 870,000 | 647,019 | 6,225,693 | 5.4 M to 6.2 M (+16.24 %) |
| Nov 04 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.61 | 336,300 | 204,067 | 6,561,993 | 6.2 M to 6.6 M (+5.40 %) |
| Oct 02 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 0.97 | 650,000 | 627,900 | 5,355,693 | 4.7 M to 5.4 M (+13.81 %) |
| Sep 29 2008 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Buy | P | 1.04 | 600,000 | 622,680 | 5,619,058 | 5 M to 5.6 M (+11.95 %) |
| Sep 23 2008 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Buy | P | 0.98 | 1,080,852 | 1,058,478 | 4,839,058 | 3.8 M to 4.8 M (+28.76 %) |
| Sep 25 2008 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Buy | P | 0.98 | 80,000 | 78,520 | 5,019,058 | 4.9 M to 5 M (+1.62 %) |
| Sep 24 2008 | VNDA | Vanda Pharmaceutic ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 100,000 | 99,880 | 4,939,058 | 4.8 M to 4.9 M (+2.07 %) |
| Sep 03 2008 | THLD | THRESHOLD PHARMACE ... | TANG KEVIN C | 10% Owner | Option Exercise | P | 2.34 | 294,117 | 688,234 | 294,117 | |
| Sep 03 2008 | THLD | THRESHOLD PHARMACE ... | TANG KEVIN C | 10% Owner | Buy | P | 2.04 | 735,294 | 1,500,000 | 1,399,877 | 664.6 K to 1.4 M (+110.64 %) |
| Sep 26 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.32 | 56,819 | 18,313 | 10,321,983 | 10.3 M to 10.3 M (+0.55 %) |
| Sep 30 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.33 | 25,763 | 8,466 | 10,403,842 | 10.4 M to 10.4 M (+0.25 %) |
| Sep 25 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.30 | 13,250 | 3,975 | 10,265,164 | 10.3 M to 10.3 M (+0.13 %) |
| Sep 29 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.33 | 56,096 | 18,399 | 10,378,079 | 10.3 M to 10.4 M (+0.54 %) |
| Sep 24 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.32 | 100,200 | 31,603 | 10,251,914 | 10.2 M to 10.3 M (+0.99 %) |
| Sep 23 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.30 | 401,600 | 121,685 | 10,151,714 | 9.8 M to 10.2 M (+4.12 %) |
| Sep 22 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.27 | 1,251,900 | 331,879 | 9,750,114 | 8.5 M to 9.8 M (+14.73 %) |
| Sep 19 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.24 | 320,800 | 75,677 | 8,498,214 | 8.2 M to 8.5 M (+3.92 %) |
| Sep 19 2008 | NTEC | NEOSE TECHNOLOGIES ... | TANG KEVIN C | 10% Owner | Buy | P | 0.30 | 705,000 | 210,020 | 8,177,414 | 7.5 M to 8.2 M (+9.43 %) |
| Sep 19 2008 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | X | 10.85 | 24,000 | 260,400 | 0 | |
| Sep 19 2008 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | X | 0.00 | 5,700 | 0 | 3,163,460 | 3.2 M to 3.2 M (+0.18 %) |
| May 09 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.80 | 23,575 | 42,421 | 4,688,713 | 4.7 M to 4.7 M (+0.51 %) |
| May 09 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.80 | 8,100 | 14,580 | 4,665,138 | 4.7 M to 4.7 M (+0.17 %) |
| May 09 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.81 | 25,000 | 45,250 | 4,657,038 | 4.6 M to 4.7 M (+0.54 %) |
| May 09 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.83 | 100,000 | 183,160 | 4,632,038 | 4.5 M to 4.6 M (+2.21 %) |
| May 14 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.80 | 37,300 | 67,039 | 4,757,038 | 4.7 M to 4.8 M (+0.79 %) |
| May 14 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.78 | 17,130 | 30,533 | 4,719,738 | 4.7 M to 4.7 M (+0.36 %) |
| May 14 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.80 | 13,895 | 25,011 | 4,702,608 | 4.7 M to 4.7 M (+0.30 %) |
| May 06 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.83 | 100,000 | 183,000 | 4,532,038 | 4.4 M to 4.5 M (+2.26 %) |
| Apr 28 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.79 | 25,000 | 44,750 | 4,182,038 | 4.2 M to 4.2 M (+0.60 %) |
| Apr 28 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.77 | 35,000 | 61,950 | 4,157,038 | 4.1 M to 4.2 M (+0.85 %) |
| Apr 28 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.79 | 150,000 | 269,025 | 4,122,038 | 4 M to 4.1 M (+3.78 %) |
| Apr 28 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.81 | 170,000 | 307,598 | 3,972,038 | 3.8 M to 4 M (+4.47 %) |
| May 01 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.82 | 50,000 | 91,000 | 4,432,038 | 4.4 M to 4.4 M (+1.14 %) |
| May 01 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.81 | 200,000 | 361,360 | 4,382,038 | 4.2 M to 4.4 M (+4.78 %) |
| Apr 18 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.80 | 36,700 | 66,060 | 3,802,038 | 3.8 M to 3.8 M (+0.97 %) |
| Apr 18 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.78 | 67,600 | 120,585 | 3,765,338 | 3.7 M to 3.8 M (+1.83 %) |
| Apr 18 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.79 | 100,000 | 179,330 | 3,697,738 | 3.6 M to 3.7 M (+2.78 %) |
| Apr 15 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.77 | 120,000 | 212,244 | 3,597,738 | 3.5 M to 3.6 M (+3.45 %) |
| Apr 15 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.77 | 6,438 | 11,413 | 3,477,738 | 3.5 M to 3.5 M (+0.19 %) |
| Apr 15 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.79 | 41,587 | 74,611 | 3,471,300 | 3.4 M to 3.5 M (+1.21 %) |
| Apr 15 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.81 | 25,000 | 45,250 | 3,429,713 | 3.4 M to 3.4 M (+0.73 %) |
| Apr 15 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.81 | 58,413 | 105,669 | 3,404,713 | 3.3 M to 3.4 M (+1.75 %) |
| Apr 10 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.81 | 50,000 | 90,405 | 3,346,300 | 3.3 M to 3.3 M (+1.52 %) |
| Apr 10 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.81 | 5,900 | 10,679 | 3,296,300 | 3.3 M to 3.3 M (+0.18 %) |
| Apr 10 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.83 | 25,000 | 45,750 | 3,290,400 | 3.3 M to 3.3 M (+0.77 %) |
| Apr 07 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.84 | 50,000 | 92,030 | 3,265,400 | 3.2 M to 3.3 M (+1.56 %) |
| Apr 07 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.87 | 100,000 | 187,000 | 3,215,400 | 3.1 M to 3.2 M (+3.21 %) |
| Apr 07 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.82 | 120,000 | 218,532 | 3,115,400 | 3 M to 3.1 M (+4.01 %) |
| Apr 04 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.71 | 498,000 | 850,933 | 2,995,400 | 2.5 M to 3 M (+19.94 %) |
| Apr 04 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.71 | 27,700 | 47,400 | 2,497,400 | 2.5 M to 2.5 M (+1.12 %) |
| Apr 03 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.67 | 70,000 | 117,194 | 2,469,700 | 2.4 M to 2.5 M (+2.92 %) |
| May 16 2008 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | C | 0.00 | 162 | 0 | 0 | |
| May 16 2008 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | C | 0.00 | 852,308 | 0 | 3,157,760 | 2.3 M to 3.2 M (+36.97 %) |
| Apr 29 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 5,236 | 5,236 | 4,705,693 | 4.7 M to 4.7 M (+0.11 %) |
| Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 10,160 | 10,160 | 4,700,457 | 4.7 M to 4.7 M (+0.22 %) |
| Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 300 | 300 | 4,690,297 | 4.7 M to 4.7 M (+0.01 %) |
| Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 25,625 | 25,617 | 4,689,997 | 4.7 M to 4.7 M (+0.55 %) |
| Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 40,000 | 40,000 | 4,664,372 | 4.6 M to 4.7 M (+0.86 %) |
| Apr 24 2008 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | 10% Owner | Buy | P | 1.00 | 619,987 | 619,987 | 4,624,372 | 4 M to 4.6 M (+15.48 %) |
| Feb 20 2008 | NPRO | TAPESTRY PHARMACEU ... | TANG KEVIN C | 10% Owner | Sell | S | 0.09 | 25,000 | 2,148 | 0 | 25 K to 0 (-100.00 %) |
| Feb 20 2008 | NPRO | TAPESTRY PHARMACEU ... | TANG KEVIN C | 10% Owner | Sell | S | 0.10 | 20,097 | 1,917 | 25,953 | 46.1 K to 26 K (-43.64 %) |
| Feb 20 2008 | NPRO | TAPESTRY PHARMACEU ... | TANG KEVIN C | 10% Owner | Sell | S | 0.09 | 258,686 | 22,221 | 46,050 | 304.7 K to 46.1 K (-84.89 %) |
| Feb 20 2008 | NPRO | TAPESTRY PHARMACEU ... | TANG KEVIN C | 10% Owner | Sell | S | 0.10 | 665,303 | 63,470 | 1,118,047 | 1.8 M to 1.1 M (-37.31 %) |
| Mar 31 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.56 | 19,000 | 29,655 | 2,399,700 | 2.4 M to 2.4 M (+0.80 %) |
| Mar 31 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.57 | 160,000 | 251,008 | 2,380,700 | 2.2 M to 2.4 M (+7.20 %) |
| Mar 31 2008 | NSTR | Northstar Neurosci ... | TANG KEVIN C | 10% Owner | Buy | P | 1.55 | 44,794 | 69,278 | 2,220,700 | 2.2 M to 2.2 M (+2.06 %) |
| Jan 04 2008 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 15.69 | 2,500 | 39,225 | 20,000 | |
| Jan 04 2008 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 15.69 | 5,000 | 78,450 | 17,500 | |
| Jan 04 2008 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 15.69 | 12,500 | 196,125 | 12,500 | |
| Dec 21 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 13.25 | 37,731 | 499,936 | 2,300,798 | 2.3 M to 2.3 M (+1.67 %) |
| Dec 06 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 12.75 | 14,000 | 178,500 | 2,263,067 | 2.2 M to 2.3 M (+0.62 %) |
| Dec 06 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 11.78 | 39,000 | 459,330 | 2,249,067 | 2.2 M to 2.2 M (+1.76 %) |
| Dec 06 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 10.76 | 53,450 | 575,069 | 2,210,067 | 2.2 M to 2.2 M (+2.48 %) |
| Dec 06 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 10.81 | 2,400 | 25,952 | 2,156,617 | 2.2 M to 2.2 M (+0.11 %) |
| Jun 19 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 5.85 | 1,250 | 7,313 | 3,750 | |
| Jun 19 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 5.85 | 2,500 | 14,625 | 2,500 | |
| Jun 13 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | X | 1.03 | 426,154 | 440,217 | 0 | |
| Jun 13 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | X | 1.03 | 426,154 | 440,217 | 2,144,896 | 1.7 M to 2.1 M (+24.79 %) |
| Jan 05 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 4.50 | 94,700 | 425,819 | 1,704,561 | 1.6 M to 1.7 M (+5.88 %) |
| Jan 05 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 4.33 | 28,732 | 124,433 | 1,609,861 | 1.6 M to 1.6 M (+1.82 %) |
| Jan 05 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 4.21 | 8,300 | 34,938 | 1,581,129 | 1.6 M to 1.6 M (+0.53 %) |
| Jan 05 2007 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 4.24 | 12,500 | 53,000 | 12,500 | |
| Dec 29 2006 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 4.32 | 93,000 | 401,500 | 196,294 | 103.3 K to 196.3 K (+90.03 %) |
| Dec 29 2006 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 4.07 | 12,300 | 50,070 | 103,294 | 91 K to 103.3 K (+13.52 %) |
| Dec 29 2006 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 4.32 | 551,968 | 2,382,956 | 1,572,829 | 1 M to 1.6 M (+54.07 %) |